Even if it's not a huge purchase, we think it was good to see that Richard Levy, the Independent Director of Protara Therapeutics, Inc. (NASDAQ:TARA) recently shelled out US$64k to buy stock, at US$3.

Stocks sold off Wednesday as Treasury yields soared. Nvidia, Palantir were losers. Still constructive? Snowflake led earnings ...